Annual report pursuant to Section 13 and 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.24.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
12 Months Ended
Jul. 12, 2017
USD ($)
Number
Jun. 12, 2017
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
General and administrative expenses     $ 14,891,000 $ 13,170,000
Standby Letters of Credit [Member]        
Standby letter of credit, amount     10,000,000  
General and administrative expenses     $ 650,000  
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member]        
Proceeds from supply agreement   $ 31,800,000    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member] | PGLG [Member]        
Percentage of right to supply   25.00%    
Agreement term   15 years    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | Revised API Agreement [Member]        
Agreement term 5 years      
Number of renewals | Number 10      
Cumulative purchase amount $ 47,000,000      
Annual purchase target amount 5,000,000      
Target profit $ 2,500,000